Adoption of antithrombotic stewardship and utilization of clinical decision support systems—A questionnaire-based survey in Dutch hospitals

Author:

Graafsma JetskeORCID,Klopotowska Joanna E.,Derijks Hieronymus J.,van de Garde Ewoudt M. W.,Hoge Rien H. L.,Kruip Marieke J. H. A.ORCID,Meijer Karina,Karapinar-Carkit Fatma,van den Bemt Patricia M. L. A.

Abstract

Antithrombotics require careful monitoring to prevent adverse events. Safe use can be promoted through so-called antithrombotic stewardship. Clinical decision support systems (CDSSs) can be used to monitor safe use of antithrombotics, supporting antithrombotic stewardship efforts. Yet, previous research shows that despite these interventions, antithrombotics continue to cause harm. Insufficient adoption of antithrombotic stewardship and suboptimal use of CDSSs may provide and explanation. However, it is currently unknown to what extent hospitals adopted antithrombotic stewardship and utilize CDSSs to support safe use of antithrombotics. A semi-structured questionnaire-based survey was disseminated to 12 hospital pharmacists from different hospital types and regions in the Netherlands. The primary outcome was the degree of antithrombotic stewardship adoption, expressed as the number of tasks adopted per hospital and the degree of adoption per task. Secondary outcomes included characteristics of CDSS alerts used to monitor safe use of antithrombotics. All 12 hospital pharmacists completed the survey and report to have adopted antithrombotic stewardship in their hospital to a certain degree. The median adoption of tasks was two of five tasks (range 1–3). The tasks with the highest uptake were: drafting and maintenance of protocols (100%) and professional’s education (58%), while care transition optimization (25%), medication reviews (8%) and patient counseling (8%) had the lowest uptake. All hospitals used a CDSS to monitor safe use of antithrombotics, mainly via basic alerts and less frequently via advanced alerts. The most frequently employed alerts were: identification of patients using a direct oral anticoagulant (DOAC) or a vitamin K antagonist (VKA) with one or more other antithrombotics (n = 6) and patients using a VKA to evaluate correct use (n = 6), both reflecting basic CDSS. All participating hospitals adopted antithrombotic stewardship, but the adopted tasks vary. CDSS alerts used are mainly basic in their logic.

Funder

Landelijk Coördinatiecentrum Geneesmiddelen

Publisher

Public Library of Science (PLoS)

Reference45 articles.

1. Van den Bemt P, Egberts A, Leenderste A. Hospital Admissions Related to Medication (HARM); een prospectief, multicenter onderzoek naar geneesmiddel gerelateerde ziekenhuisopnames; eindrapport HARM-onderzoek. 2006.

2. Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands;F Lghoul-Oulad Saïd;Pharmacoepidemiol Drug Saf,2020

3. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis;O Laatikainen;Eur J Clin Pharmacol,2017

4. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force;MF Warlé-van Herwaarden;Drug Saf,2012

5. Dutch guideline on integrated antithrombotic care. Landelijke Standaard Ketenzorg Antistolling. 2014 vs 1.0 2012 and vs 2.0.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3